ClinicalTrials.gg
Not yet recruitingNCT07098702Updated Aug 1, 2025

Effect of Ergonomic Practices on Quality of Breastfeeding

An interventional study of educational sessions and booklet and No Interventions in we Search for the Effect of Ergonomic Practices on Quality of Breastfeeding, sponsored by Mansoura University. Not yet recruiting. Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-01.

Sponsored by Mansoura University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
104
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

This study aims to assess the effectiveness of ergonomic practices on quality of breastfeeding among primiparous.

Read the detailed description

Prolonged discomfort experienced during lactation can significantly impede a mother's adjustment to the maternal role. This discomfort arises from suboptimal body positioning and extended periods of sitting during breastfeeding and some mothers stop breastfeeding as a result of that. Consequently, the promotion of maternal comfort during breastfeeding will enhance the quality of breastfeeding, and this will be achieved by encouraging mothers to assume appropriate body mechanics, appropriate breastfeeding positions, and use breastfeeding pillows during breastfeeding. Therefore, the researcher will conduct the current study.

02

Conditions studied

  • we Search for the Effect of Ergonomic Practices on Quality of Breastfeeding

Browse trials for

Keywords

  • Ergonomic Practices, Latch, Primiparous, Quality of Breastfeeding, Weight
03

In context

Body Weight

657 studies on the registry are indexed under Body Weight; 76 are open to participants now.

This study's planned enrollment of 104 is above the median of 71 across 500 interventional studies indexed under Body Weight.

Browse Body Weight studies →

Lead sponsor

Mansoura University is the lead sponsor of 1,119 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1) Nulliparous women, 2) Mothers between the ages of 18 and 35, 3) Mothers who are in the third trimester, 4) Singleton pregnancy, 5) Mothers who have the intention of breastfeeding, and 6) Mothers who can read and write.

Exclusion criteria

Exclusion Criteria:

  • 1) Mothers with nipple problems, such as flat or inverted nipples, and 2) Mothers with medical or surgical problems interfering with breastfeeding.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
104 participants (estimated)

Study arms

  • Experimental
    intervention group

    In this group, the mothers will receive educational sessions regarding appropriate ergonomic practices during breastfeeding which include appropriate body mechanics, breastfeeding positions and breastfeeding pillows

    Other: educational sessions and booklet

  • Experimental
    control group

    Other: No Interventions

Interventions

  • Othereducational sessions and booklet

    educational sessions and booklet about ergonomic practices during breastfeeding which include appropriate body mechanics , breastfeeding positions, and use of breastfeeding pillows.

  • OtherNo Interventions

    In this group, the mothers will breastfeed their newborns according to the routine hospital postpartum instructions only.

06

What researchers measure

Primary outcomes

  1. A LATCH score

    A LATCH score of 0 to 3 is regarded as poor quality of breastfeeding, 4 to 7 is considered as moderate quality of breastfeeding, and 8 to 10 is considered as good quality of breastfeeding.

    Time frame: At two weeks and two, four and six months after delivery

Secondary outcomes

  1. Change in the growth chart of the infants

    neonates of the intervention group will exhibit better growth than neonates of the control group

    Time frame: At two weeks and two, four, and six months after delivery

07

Study locations

No study locations are listed for this record.

08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2025; primary completion for May 2026, 9 months later.

Of 206 non-industry interventional studies with no phase under Body Weight, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 40. This study's planned 9 months is below that.

Counting every sponsor, half of 226 studies reached it within 18 months; a quarter within 7 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2025
First posted
Aug 1, 2025
StartEst.
Aug 20, 2025
Primary completionEst.
May 2026
CompletionEst.
Jul 2026
Last update
Aug 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07098702
Responsible party
Aida Mohamed Ali Abd-Ellatif (Clinical Instructor at Technical Institute of Nursing, Faculty of Nursing, Mansoura University, Mansoura University) — Principal investigator
First posted
Aug 1, 2025
Start date
Aug 20, 2025 (estimated)
Primary completion
May 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Aug 1, 2025

Study contacts

Aida Mohamed Ali Abd-Ellatif Omar, Master student
Contact
aidamoh@std.mans.edu.eg
+20 01012751401
Enas Sabry Fathy Elbeltagy, Lecturer
Contact
enassabry25@mans.edu.eg
+20 01067364685
Hanan El-Sayed Mohamed El-Sayed, Professor
study chair · Faculty of Nursing, Mansoura University, Egypt
Reda Abd El-Hady Ali Hemeda, Professor
principal investigator · Faculty of Medicine, Mansoura University, Egypt
Enas Sabry Fathy Elbeltagy, Lecturer
principal investigator · Faculty of Nursing, Mansoura University, Egypt

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion